Midnapore Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 19-07-2024
- Paid Up Capital ₹ 1.03 M
as on 19-07-2024
- Company Age 22 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.88 Cr
as on 19-07-2024
- Satisfied Charges ₹ 4.00 Cr
as on 19-07-2024
- Revenue 18.81%
(FY 2023)
- Profit 23.15%
(FY 2023)
- Ebitda 22.39%
(FY 2023)
- Net Worth 26.25%
(FY 2023)
- Total Assets 25.06%
(FY 2023)
About Midnapore Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.03 M.
The company currently has active open charges totaling ₹5.88 Cr. The company has closed loans amounting to ₹4.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sukesh Agarwal, Govind Agarwal, Biswanath Roy, and One other member serve as directors at the Company.
- CIN/LLPIN
U85195WB2002PTC095184
- Company No.
095184
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Sep 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Midnapore Diagnostics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukesh Agarwal  | Director | 19-May-2005 | Current |
| Govind Agarwal | Director | 18-Sep-2002 | Current |
| Biswanath Roy | Director | 31-Mar-2003 | Current |
| Narayan Agarwal | Director | 19-May-2005 | Current |
Financial Performance of Midnapore Diagnostics.
Midnapore Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.81% increase. The company also saw a substantial improvement in profitability, with a 23.15% increase in profit. The company's net worth Soared by an impressive increase of 26.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Midnapore Diagnostics?
In 2023, Midnapore Diagnostics had a promoter holding of 98.27% and a public holding of 1.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Hazarlakh Finance LimitedActive 8 years 1 month
Govind Agarwal and Narayan Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Feb 2023 | ₹5.88 Cr | Open |
West Bengal Financial Corporation Creation Date: 14 May 2003 | ₹4.00 Cr | Satisfied |
How Many Employees Work at Midnapore Diagnostics?
Midnapore Diagnostics has a workforce of 203 employees as of Jul 16, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Midnapore Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Midnapore Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
